APA (7th ed.) Citation

Østergaard, S., Jessen, C., Paulsson, J. F., Kasimova, M. A., Conde-Frieboes, K. W., Straarup, E. M., . . . Chambers, A. P. (2025). Variant screening of PYY 3-36 leads to potent long-acting PYY analogs with superior Y 2 receptor selectivity. Science translational medicine, 17(791), eadq6392. https://doi.org/10.1126/scitranslmed.adq6392

Chicago Style (17th ed.) Citation

Østergaard, Søren, et al. "Variant Screening of PYY 3-36 Leads to Potent Long-acting PYY Analogs with Superior Y 2 Receptor Selectivity." Science Translational Medicine 17, no. 791 (2025): eadq6392. https://doi.org/10.1126/scitranslmed.adq6392.

MLA (9th ed.) Citation

Østergaard, Søren, et al. "Variant Screening of PYY 3-36 Leads to Potent Long-acting PYY Analogs with Superior Y 2 Receptor Selectivity." Science Translational Medicine, vol. 17, no. 791, 2025, p. eadq6392, https://doi.org/10.1126/scitranslmed.adq6392.